ALKEM

Alkem Laboratories Limited

Pharmaceuticals

Share price

₹5,292

Market cap

₹62,926 Cr

1Y return

▼ 3%

A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.

Investors holding Alkem Laboratories Limited

HDFC Mutual Fund

Mutual Fund

4.77%

Ashok Kumar Jain

Investor

2.25%

SBI Mutual Fund

Mutual Fund

1.99%

Institution

1.43%

HDFC Life Insurance

Institution

1.31%

Recent moves 17

Moves17

HDFC Mutual FundIncreased

HDFC Mutual Fund bought 25,019 shares of Alkem Laboratories in the open market. This purchase raised its stake from 5.00% to 5.02%, crossing the 5% disclosure threshold.

LIC decreased its stake in Alkem Laboratories by selling 147,955 shares, reducing its holding from 1.56% to 1.43%. The value of the shares sold is ₹82.26 crore at ₹5563.00 apiece.

SBI Mutual FundDecreased

SBI Mutual Fund decreased its stake in Alkem Laboratories from 2.42% to 1.99%, selling 508,608 shares for ₹283.05 crore at ₹5563.00 apiece.

HDFC Life InsuranceDecreased

HDFC Life Insurance decreased its stake in Alkem Laboratories from 1.33% to 1.31%, selling 34,427 shares.

DSP Mutual FundIncreased

DSP Mutual Fund increased its stake in Alkem Laboratories from 1.45% to 1.78% by purchasing 398,949 shares for ₹223.61 crore at ₹5606.00 apiece.

Nippon India Mutual FundDecreased

Nippon India Mutual Fund reduced its stake in Alkem Laboratories from 1.93% to 1.87%, selling 69,681 shares for ₹39.06 crore.

ICICI Prudential Mutual FundIncreased

ICICI Prudential Mutual Fund increased its stake in Alkem Laboratories from 3.10% to 3.57%, acquiring an additional 5,62,664 shares. This includes the purchase of 9.03 lakh shares for ₹469.83 crore at ₹5,200 apiece in a block deal on June 2, 2026.

BNP ParibasNew position

BNP Paribas bought 48,090 shares of Alkem Laboratories for ₹25.01 Cr at ₹5200.00 apiece in a block deal. This was part of a larger transaction where promoter family entities divested shares to various institutional investors.

Societe GeneraleNew position

Societe Generale bought 48,090 shares of Alkem Laboratories for ₹25.01 Cr at ₹5200.00 apiece in a block deal.

Nippon India Mutual FundNew position

Nippon India Mutual Fund bought 48,090 shares of Alkem Laboratories for ₹25.01 crore at ₹5200.00 per share in a block deal on June 2, 2026. This was part of a larger transaction where promoter group entities sold a 1.5% stake in the company.

Track the whales in Alkem Laboratories Limited

Get alerted the moment a top investor buys or sells.